Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liyan Jiang

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Oncotarget|October 4, 2017
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patientsLiwen Xiong, Shaohua Cui, Jingyan Ding, et al.
Microbes and Infection|January 9, 2023
Genetic recombination of Orientia tsutsugamushi strains from scrub typhus patients in Guangxi, Southwest China, and the analysis of clinical featuresMiao Lu, Dongsheng Zhou, Siyan Xie, et al.
British Journal of Cancer|February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)Baohui Han, Kai Li, Yizhuo Zhao, et al.
Clinical Lung Cancer|January 5, 2016
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung CancerJianlin Xu, Tianqing Chu, Bo Jin, et al.
Nucleic Acids Research|November 19, 2015
BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing dataWei Zhu, Michael Kuziora, Todd Creasy, et al.
Cancer Genetics|November 9, 2013
Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patientsLiyan Jiang, Jiaqi Huang, Chris Morehouse, et al.
Nature Communications|January 13, 2021
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunityBotai Li, Lili Zhu, Chunlai Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2024
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 StudyYuankai Shi, Xingsheng Hu, Xingya Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2024
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL StudyShun Lu, Lin Wu, Qiming Wang, et al.
Academic Radiology|May 22, 2025
Right Ventricular Strain as a Key Feature in Interpretable Machine Learning for Identification of Takotsubo Syndrome: A Multicenter CMR-based StudyZeliu Du, Hongfei Hu, Chenqi Shen, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Oncotarget|October 4, 2017
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patientsLiwen Xiong, Shaohua Cui, Jingyan Ding, et al.
Microbes and Infection|January 9, 2023
Genetic recombination of Orientia tsutsugamushi strains from scrub typhus patients in Guangxi, Southwest China, and the analysis of clinical featuresMiao Lu, Dongsheng Zhou, Siyan Xie, et al.
British Journal of Cancer|February 14, 2018
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)Baohui Han, Kai Li, Yizhuo Zhao, et al.
Clinical Lung Cancer|January 5, 2016
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Squamous Cell Lung CancerJianlin Xu, Tianqing Chu, Bo Jin, et al.
Nucleic Acids Research|November 19, 2015
BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing dataWei Zhu, Michael Kuziora, Todd Creasy, et al.
Cancer Genetics|November 9, 2013
Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patientsLiyan Jiang, Jiaqi Huang, Chris Morehouse, et al.
Nature Communications|January 13, 2021
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunityBotai Li, Lili Zhu, Chunlai Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2024
Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 StudyYuankai Shi, Xingsheng Hu, Xingya Li, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2024
Durvalumab Versus Chemotherapy as First-line Treatment for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or Higher: Results From the Randomized Phase 3 PEARL StudyShun Lu, Lin Wu, Qiming Wang, et al.
Academic Radiology|May 22, 2025
Right Ventricular Strain as a Key Feature in Interpretable Machine Learning for Identification of Takotsubo Syndrome: A Multicenter CMR-based StudyZeliu Du, Hongfei Hu, Chenqi Shen, et al.
Pageof 17